INCA033989 May Address Need for Disease-Modifying Therapies in Myelofibrosis

Retrieved on: 2024-10-25 13:01:14

Tags for this article:

Click the tags to see associated articles and topics

INCA033989 May Address Need for Disease-Modifying Therapies in Myelofibrosis. View article details on hiswai:

Excerpt

Unlike the array of JAK inhibitors available for the treatment of patients with myelofibrosis, the novel monoclonal antibody INCA033989 may have ...

Article found on: www.onclive.com